Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Friends Research Institute, Inc. |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000245 |
The purpose of this study is to confirm whether a blood level ""ceiling"" exists on desipramine effect in cocaine abuse.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders Substance-Related Disorders |
Drug: Desipramine |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Evaluation of a Desipramine Ceiling in Cocaine Abuse |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
United States, California | |
Friends Research Institute | |
Los Angeles, California, United States, 90025 |
Principal Investigator: | Frank Gawin, M.D. | Friends Research Institute, Inc. |
Study ID Numbers: | NIDA-08082-1, R01-08082-1 |
Study First Received: | September 20, 1999 |
Last Updated: | August 16, 2005 |
ClinicalTrials.gov Identifier: | NCT00000245 |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Mental Disorders Substance-Related Disorders |
Disorders of Environmental Origin Desipramine Cocaine |
Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Disease Molecular Mechanisms of Pharmacological Action Adrenergic Agents Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs |
Enzyme Inhibitors Pharmacologic Actions Antidepressive Agents, Tricyclic Pathologic Processes Therapeutic Uses Central Nervous System Agents Antidepressive Agents |